What is Aesop Technology?
Founded in 2019 as a spin-off from Taipei Medical University, Aesop Technology is at the forefront of medical informatics. Comprised of experts in medical informatics, physicians, and pharmacists, the company's mission is to enhance patient safety and elevate quality through the deployment of next-generation AI in prescription processes. Their innovative technology aims to refine clinical decision support, thereby improving patient safety and the accuracy of medical coding.
How much funding has Aesop Technology raised?
Aesop Technology has raised a total of $3M across 1 funding round:
Other Financing Round
$3M
Other Financing Round (2022): $3M with participation from Taiwania Capital, 500 Global, Colopl Next, and BE Capital
Key Investors in Aesop Technology
Taiwania Capital
Taiwania Capital is an investor participating in the funding round.
500 Global
500 Global is a venture capital firm that invests in companies across the globe, focusing on early-stage startups.
Colopl Next
Colopl Next is a venture capital firm established in 2015 that invests in a wide range of startups across various industries, focusing on companies in Japan, the U.S., and South Korea, particularly in BtoC entertainment sectors.
What's next for Aesop Technology?
The substantial enterprise-level backing positions Aesop Technology for accelerated growth and market penetration. This strategic investment is expected to fuel further development of their AI-powered solutions, enabling broader adoption within healthcare systems. The company is poised to solidify its position as a leader in optimizing clinical decision-making and enhancing patient outcomes through advanced technology.
See full Aesop Technology company page
